Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: A longitudinal cohort study

BMC Health Services Research

Volumn 10, Issue , 2010, Pages

  Blumenthal, Karen J ^a   Larkin, Mary E ^a   Winning, Gail ^a   Nathan, David M ^a,b   Grant, Richard W ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; DYSLIPIDEMIA; FEMALE; GENERAL HOSPITAL; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; STATISTICAL MODEL; UNITED STATES;

ADULT; AGED; ANALYSIS OF VARIANCE; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS, GENERAL; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MASSACHUSETTS; MIDDLE AGED;

EID: 77953228894     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-10-158     Document Type: Article

References (18)

1. National Diabetes Fact Sheet. Center for Disease Control and Prevention, General information and national estimates on diabetes in the United States, 2005 Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2005
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. Diabetes Control and Complications Trial Research Group, N Engl J Med 1993 329 977 986 10.1056/NEJM199309303291401 8366922
3. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group, Lancet 1998 352 837 853 10.1016/S0140-6736(98)07019-6 9742976
4. 1c-independent risk factor for diabetic complications. M Brownlee IB Hirsch, JAMA 2006 295 1707 1708 10.1001/jama.295.14.1707 16609094
5. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial. Heart Protection Study Collaborative Group, Lancet 2003 361 9374 2005 2016 10.1016/S0140-6736(03)13636-7 12814710
6. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. P Gaede P Vedel N Larsen GV Jensen HH Parving O Pedersen, N Engl J Med 2003 348 1925 1927 10.1056/NEJMoa021778 (Pubitemid 36159355)
7. Trends in A1c concentrations among U.S. adults with diagnosed diabetes from 1999 to 2004. ES Ford C Li RR Little AH Mokhad, Diabetes Care 2008 31 102 104 10.2337/dc07-0565 17934146
8. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes. CE Koro SJ Bowlin N Bourgeois DO Fedder, Diabetes Care 2004 27 17 20 10.2337/diacare.27.1.17 14693960
9. Glycemic control in diabetes mellitus: have changes in therapy made a difference? DM Nathan C McKitrick M Larkin R Schaffran DE Singer, Am J Med 1996 100 157 163 10.1016/S0002-9343(97)89453-3 8629649
10. Factors driving diabetes care improvement in a large medical group: ten years of progress. JM Sperl-Hillen PJ O'Connor, Am J Manag Care 2005 11 177 S185 16111440
11. Frequent outpatient contact and decreasing medication affordability in patients with diabetes from 1997 to 2004. RW Grant EP McCarthy DE Singer JB Meigs, Diabetes Care 2006 29 1386 1388 10.2337/dc06-0196 16732027
12. The social security administration's death master file: the completeness of death reporting at older ages. ME Hill I Rosenwaike, Social Security Bulletin 2001/2002 64 45 51
13. Labile glycosylated hemoglobin contributes to hemoglobin A1c as measured by liquid chromatography or electrophoresis. D Nathan, Clin Chem 1981 27 1261 1263 7237794
14. The clinical information value of the glycosylated hemoglobin assay. DM Nathan DE Singer K Hurxthal JD Goodson, N Engl J Med 1984 310 341 346 6690962
15. Automated enzymatic standardized lipid analyses for plasma and lipid lipoprotein fractions. J McNamara E Schaefer, Clin Chim Acta 1987 166 1 8 10.1016/0009-8981(87)90188-4 3608193
16. Dextran sulfate-magnesium precipitation procedure for quantitation of high-density lipoprotein cholesterol. G Warnick J Benderson J Albers, Clin Chem 1982 28 1379 1382 7074948
17. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. W Friedewald R Levy D Fredrickson, Clin Chem 1972 18 499 502 4337382
18. Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1c < 7%. L Pani DM Nathan RW Grant, Diabetes Care 2008 31 386 390 10.2337/dc07-1934 18083790